Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04943393 · ClinicalTrials.gov registry record
Remote Neurocognitive and Psychological Assessment in PKU
A clinical trial of Phenylketonurias, sponsored by University of Missouri-Columbia.
- Completed
- Registry status
- 84
- Enrollment target
- 2
- Study locations
NCT04943393 is a study of Phenylketonurias that has completed, run by University of Missouri-Columbia. The registered enrollment target is 84 participants, above the 29-participant average among 5 other Phenylketonurias trials with a reported enrollment target (190% higher). The trial reports 2 study locations across 2 states.
The verdict
NCT04943393, a study of Phenylketonurias, has completed, sponsored by University of Missouri-Columbia.
- COMPLETED
- Registry status
- 84 participants
- Enrollment target
- 2
- Study locations
Study Summary
PKU is a rare autosomal recessive condition associated with disruption in dopamine synthesis. Although early diagnosis and treatment prevent the severe impairments associated with untreated PKU, individuals with early-treated PKU (ETPKU) nonetheless experience significant sequelae, including impaired working memory and increased risk for anxiety problems. Past research with other clinical populations (e.g., generalized anxiety disorder) suggests that the two phenomena may be linked, with increased anxiety contributing to poorer WM performance. Currently we propose to initiate an exciting new line of research examining the potential relationship between anxiety and WM in ETPKU. The proposed study will also apply remote neuropsychological performance-based assessment to the study of ETPKU and thus overcoming the geographical limitations/challenges associated with recruitment of participants with this rare disease.
Conditions Studied
Interventions
- OTHER nointervention
Study Locations (2)
Georgia
- Emory University - Atlanta
Missouri
- University of Missouri - Columbia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2020-11-24 |
| Est. Completion | 2021-10-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04943393
The ClinicalTrials.gov registry entry for NCT04943393 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 29-participant average among 5 other Phenylketonurias trials with a reported enrollment target (190% higher). The listed sponsor is University of Missouri-Columbia, which has 291 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Phenylketonurias appearing as the primary indexed condition, and to 1 intervention - of which nointervention is the first listed.
NCT04943393 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Georgia, Missouri.
Frequently Asked Questions
What is clinical trial NCT04943393 about?
NCT04943393 is a clinical study titled "Remote Neurocognitive and Psychological Assessment in PKU". PKU is a rare autosomal recessive condition associated with disruption in dopamine synthesis. Although early diagnosis and treatment prevent the severe impairments associated with untreated PKU, individuals with early-treated PKU (ETPKU) nonetheless experience significant sequelae, including impaire...
What is the current status of trial NCT04943393?
This trial is currently completed. The enrollment target is 84 participants. The study started on 2020-11-24. Estimated completion is 2021-10-02.
What conditions does trial NCT04943393 study?
This clinical trial studies the following conditions: Phenylketonurias.
What interventions are being tested in trial NCT04943393?
The interventions under investigation include: nointervention (OTHER).
Who is sponsoring clinical trial NCT04943393?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04943393 being conducted?
This trial has 2 study locations across Georgia, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Phenylketonurias
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
AAV Gene Therapy Clinical Study in Adult Classic PKU (PHEdom)
RECRUITING · Phase 1
-
Development of Novel Psychological Assessment Tools and Anxiety Intervention for Phenylketonuria
RECRUITING · NA
-
Nutritional Impacts of Palynziq on Patients With Phenylketonuria (PKU)
RECRUITING
-
Bone Mineral Density in Adults With Hyperphenylalaninemia
COMPLETED
-
PheCheck Feasibility Study
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.